GW&K Investment Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9K Sell
125
-25
-17% -$1.35K ﹤0.01% 936
2026
Q1
$8K Sell
150
-10
-6% -$600 ﹤0.01% 901
2025
Q4
$9K Buy
160
+10
+7% +$608 ﹤0.01% 876
2025
Q3
$8K Buy
150
+26
+21% +$1.39K ﹤0.01% 889
2025
Q2
$6K Buy
124
+98
+377% +$4.92K ﹤0.01% 909
2025
Q1
$2K Sell
26
-21
-45% -$1.42K ﹤0.01% 976
2024
Q4
$3K Buy
47
+7
+18% +$514 ﹤0.01% 909
2024
Q3
$3K Buy
40
+14
+54% +$1.05K ﹤0.01% 900
2024
Q2
$2K Buy
26
+1
+4% +$74 ﹤0.01% 895
2024
Q1
$2K Buy
25
+3
+14% +$215 ﹤0.01% 871
2023
Q4
$2K Buy
+22
New +$1.45K ﹤0.01% 878
2023
Q3
Sell
-6
Closed 935
2023
Q2
$0 Buy
+6
New +$482 ﹤0.01% 918
2022
Q3
Sell
-48
Closed -$4K 773
2022
Q2
$4K Buy
48
+24
+100% +$2.25K ﹤0.01% 654
2022
Q1
$3K Buy
+24
New +$2.48K ﹤0.01% 656

Other funds holding TECH

GW&K Investment Management's TECH Position: Q2 2026 in Review

GW&K Investment Management reduced its Bio-Techne (TECH) stake by 17% in Q2 2026, selling an estimated $1.35K and leaving 125 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #936.

GW&K Investment Management first reported a position in TECH in Q1 2022 and has held it in 14 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • GW&K Investment Management held 125 shares of Bio-Techne worth $9K as of Q2 2026.
  • GW&K Investment Management sold 25 Bio-Techne shares in Q2 2026, an estimated $1.35K.
  • Bio-Techne made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #936 holding.
  • GW&K Investment Management first reported a position in Bio-Techne in Q1 2022 and has held it in 14 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.